Regulatory T-cell Subset Analysis and Profile of Interleukin (IL)-10, IL-17 and Interferon-gamma Cytokine-producing Cells in Kidney Allograft Recipients with Donor Cells Infusion
Overview
Authors
Affiliations
Background: This pilot study aimed to assess whether the perioperative infusion of donor bone marrow cells (DBMC) in renal allograft recipients can affect the appearance of peripheral regulatory T-cell subsets and the profile of cytokine-producing cells [interferon-gamma (IFN-γ), interleukin (IL)-17 and IL-10] 2 years after transplantation.
Methods: Fresh blood samples were collected from 14 kidney recipients who received infusion and from 13 kidney recipients without infusion who served as controls at the end of the second post-transplantation year. Initially the percentages of CD4(+)CD25(+)FoxP3(+) T cells and CD3(+)CD8(+)CD28(-) T cells were quantified using flowcytometry. Thereafter, the frequencies of IL-10-, IL-17- and IFN-γ-producing cells were determined separately using the ELISPOT technique with peptides corresponding to mismatched donor HLA-DR molecules and phytohemagglutinin (PHA).
Results: The mean numbers of IFN-γ- and IL-17-producing cells in response to PHA were lower in infused patients than in controls (P = 0.02 and P = 0.18, respectively); however, an increased frequency of IL-10-producing cells was observed compared to controls (P = 0.07). Furthermore, the ratio of IL-10/IFN-γ-producing cells was significantly higher in the DBMC-infused group versus controls (P = 0.01). There was a negative correlation between the percentage of CD3(+)CD8(+)CD28(-)T cells and IL-17-producing cells in the infused group (r = -0.539, P = 0.04). The mean levels and the frequency of microchimerism within the first post-transplantation year were also significantly higher in infused patients than in controls (P = 0.007 and P = 0.001, respectively).
Conclusion: Our findings suggest that DBMC infusion could partially stimulate the regulatory mechanisms against alloimmune responses in kidney allograft recipients
Regulation of Treg cells by cytokine signaling and co-stimulatory molecules.
Zong Y, Deng K, Chong W Front Immunol. 2024; 15:1387975.
PMID: 38807592 PMC: 11131382. DOI: 10.3389/fimmu.2024.1387975.
Chen P, Cepika A, Agarwal-Hashmi R, Saini G, Uyeda M, Louis D Sci Transl Med. 2021; 13(617):eabf5264.
PMID: 34705520 PMC: 9451143. DOI: 10.1126/scitranslmed.abf5264.
Tr1 Cells as a Key Regulator for Maintaining Immune Homeostasis in Transplantation.
Song Y, Wang N, Chen L, Fang L Front Immunol. 2021; 12:671579.
PMID: 33981317 PMC: 8109434. DOI: 10.3389/fimmu.2021.671579.
Odeh A, Simecka J PLoS One. 2016; 11(5):e0155648.
PMID: 27175511 PMC: 4866680. DOI: 10.1371/journal.pone.0155648.
Mohammadi F, Niknam M, Nafar M, Einollahi B, Nazari B, Lessanpezeshki M Int J Organ Transplant Med. 2014; 4(2):77-85.
PMID: 25013657 PMC: 4089312.